Skip to main content
. 2019 Nov 2;40(2):129–137. doi: 10.1007/s40261-019-00869-3

Fig. 1.

Fig. 1

Markov model structure of nivolumab and docetaxel strategies for the treatment of patients with previously treated advanced non-small cell lung cancer (NSCLC)